Question 1

Am I eligible for this trial based on my current health and diabetes management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of dapagliflozin and metformin compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my blood sugar levels be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes clinical trial (NCT00859898). Contact the study team or your healthcare provider for specific answers.

What this study is about